Anna Maria Lena

Anna Maria Lena

Auto-generated profile, based on publicly available information

Anna Maria Lena

Department of Experimental Medicine, University of Rome “Tor Vergata

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2018 in Biochemical Journal
Verified
Journal Article
Closed access
PDF file
ECEleonora Candi
Eleonora Candi
Manfredi TesauroManfredi Tesauro
Manfredi Tesauro
CCCarmine Cardillo
Carmine Cardillo
ALAnna Maria Lena
Anna Maria Lena
FSFrancesca Schinzari
Francesca Schinzari
GMGerry Melino
Gerry Melino
Obesity represents one of the most complex public health challenges and has recently reached epidemic proportions. Obesity is also considered to be primarily responsible for the rising prevalence of metabolic syndrome, defined as the coexistence in the same individual of several risk factors for atherosclerosis, including dyslipidemia, hypertension and hyperglycemia, as well as for cancer. Additionally, the presence of three of the five risk factors (abdominal obesity, low high-density lipoprotein cholesterol, high triglycerides, high fasting glucose and high blood pressure) characterizes metabolic syndrome, which has serious clinical consequences. The current study was conducted in order to identify metabolic differences in visceral adipose tissue (VAT) collected from obese (body mass index 43–48) human subjects who were diagnosed with metabolic syndrome, obese individuals who were metabolically healthy and nonobese healthy controls. Extensive gas chromatography/mass spectrometry (GC/MS) and liquid chromatography/mass spectrometry (LC/MS/MS) analyses were used to obtain the untargeted VAT metabolomic profiles of 481 metabolites belonging to all biochemical pathways. Our results indicated consistent increases in oxidative stress markers from the pathologically obese samples in addition to subtle markers of elevated glucose levels that may be consistent with metabolic syndrome. In the tissue derived from the pathologically obese subjects, there were significantly elevated levels of plasmalogens, which may be increased in response to oxidative changes in addition to changes in glycerolphosphorylcholine, glycerolphosphorylethanolamine glycerolphosphorylserine, ceramides and sphingolipids. These data could be potentially helpful for recognizing new pathways that underlie the metabolic–vascular complications of obesity and may lead to the development of innovative targeted therapies.

15 January 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
ALAnna Maria Lena
Anna Maria Lena
VRValerio Rossi
Valerio Rossi
SOSusanne Osterburg
Susanne Osterburg
ASArtem Smirnov
Artem Smirnov
COChristian Osterburg
Christian Osterburg
ECEleonora Candi
Eleonora Candi
The transcription factor p63 mediates distinct cellular responses, primarily regulating epithelial and oocyte biology. In addition to the two amino terminal isoforms, TAp63 and ΔNp63, the 3’-end of p63 mRNA undergoes tissue-specific alternative splicing that leads to several isoforms, including p63α, p63β and p63γ. To investigate in vivo how the different isoforms fulfil distinct functions at the cellular and developmental levels, we developed a mouse model replacing the p63α with p63β by deletion of exon 13 in the Trp63 gene. Here, we report that whereas in two organs physiologically expressing p63α, such as thymus and skin, no abnormalities are detected, total infertility is evident in heterozygous female mice. A sharp reduction in the number of primary oocytes during the first week after birth occurs as a consequence of the enhanced expression of the pro-apoptotic transcriptional targets Puma and Noxa by the tetrameric, constitutively active, TAp63β isoform. Hence, these mice show a condition of ovary dysfunction, resembling human primary ovary insufficiency. Our results show that the p63 C-terminus is essential in TAp63α-expressing primary oocytes to control cell death in vivo, expanding the current understanding of human primary ovarian insufficiency.

20 April 2020 in Oncogene
Verified
Journal Article
Closed access
PDF file
Matteo CassandriMatteo Cassandri
Matteo Cassandri
ABAlessio Butera
Alessio Butera
IAIvano Amelio
Ivano Amelio
ALAnna Maria Lena
Anna Maria Lena
MMManuela Montanaro
Manuela Montanaro
GMGerry Melino
Gerry Melino

4 February 2020 in EMBO Reports
Verified
Journal Article
Open access
PDF file
EPEmanuele Panatta
Emanuele Panatta
ALAnna Maria Lena
Anna Maria Lena
MMMara Mancini
Mara Mancini
ASArtem Smirnov
Artem Smirnov
AMAlberto Marini
Alberto Marini
ECEleonora Candi
Eleonora Candi
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

5 August 2020 in Amino Acids
Verified
Journal Article
Closed access
PDF file
MPMaria Cristina Piro
Maria Cristina Piro
Manfredi TesauroManfredi Tesauro
Manfredi Tesauro
ALA. M. Lena
A. M. Lena
PGPaolo Gentileschi
Paolo Gentileschi
GSGiuseppe S. Sica
Giuseppe S. Sica
NDNicola Di Daniele
Nicola Di Daniele

3 May 2021 in Discover Oncology
Verified
Journal Article
Open access
PDF file
IIIDI IRCCS
IDI IRCCS
ACA. Cappello
A. Cappello
RPR. Pecorari
R. Pecorari
ALA. M. Lena
A. M. Lena
MMManuela Montanaro
Manuela Montanaro
ECEleonora Candi
Eleonora Candi
While non-melanoma skin cancers (NMSCs) are the most common tumours in humans, only the sub-type cutaneous squamous cell carcinoma (cSCC), might become metastatic with high lethality. We have recently identified a regulatory pathway involving the lncRNA transcript uc.291 in controlling the expression of epidermal differentiation complex genes via the interaction with ACTL6A, a component of the chromatin remodelling complex SWI/SNF. Since transcribed ultra-conserved regions (T-UCRs) are expressed in normal tissues and are deregulated in tumorigenesis, here we hypothesize a potential role for dysregulation of this axis in cSCC, accounting for the de-differentiation process observed in aggressive poorly differentiated cutaneous carcinomas. We therefore analysed their expression patterns in human tumour biopsies at mRNA and protein levels. The results suggest that by altering chromatin accessibility of the epidermal differentiation complex genes, down-regulation of uc.291 and BRG1 expression contribute to the de-differentiation process seen in keratinocyte malignancy. This provides future direction for the identification of clinical biomarkers in cutaneous SCC. Analysis of publicly available data sets indicates that the above may also be a general feature for SCCs of different origins.